期刊文献+

大豆异黄酮代谢终产物——雌马酚的研究进展 被引量:4

Advances in research on equol:a final metabolite of the soy isoflavone
下载PDF
导出
摘要 雌马酚是大豆异黄酮在人体肠道中的最终代谢产物。众多研究表明大豆异黄酮具有广泛的保健价值,在预防心血管疾病、乳腺癌和前列腺癌等方面均发挥重要作用。大豆异黄酮的生物活性在某种程度上归因于雌马酚,并且雌马酚具有较其前体更高的生物学效用。大豆异黄酮在特定的肠道菌作用下降解产生雌马酚,但并非每个人体内都可代谢产生雌马酚。总结了雌马酚在人体中的生理活性,并且综合论述了化学合成制备混合型雌马酚的方法,以及生物合成雌马酚过程中,动物及人体内可降解大豆异黄酮的肠道菌筛选情况。 Equol is the final metabolite of soy isoflavones in the human intestinal gut.Many studies have been shown that the isoflavones have a wide range of nutrition value and play an important role in the prevention of cardiovascular disease,breast and prostate cancer.The biological activities of isoflavones to some extent be attributed to equol,and equol has a higher biological activity than its precursor.Soy isoflavones can be transformed to equol exclusively by intestinal bacteria,and not everyone have this metabolic capacity.This paper overviewed the physiological activity of equol and a chemical synthesis of R-and S-equol,furthermore,about the biosynthesis of equol.We also introduced some intestinal bacteria capable of transforming soy isoflavones to equol.
出处 《食品工业科技》 CAS CSCD 北大核心 2012年第19期401-403,408,共4页 Science and Technology of Food Industry
关键词 大豆异黄酮 雌马酚 肠道菌 soy isoflavones equol intestinal bacteria
  • 相关文献

参考文献27

  • 1李琳,钱忠明.大豆异黄酮的药理作用及其研究进展[J].中国药学杂,2002,37(10):724-726. 被引量:1
  • 2Setchell KD, Brown NM, Lydeking-Olsen E.The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones [J].JNutr,2002,132(12) :3577-3584. 被引量:1
  • 3Marrian GF, Haslewood GA. Equol, a new inactive pheol isolated from the ketohydroxyoestrin fraction of mares urine [ J ] Biochem J, 1932,26 : 1227-1232. 被引量:1
  • 4Muthyala RS, Ju YH, Sheng S, et al. Equol, natural estrogenic metabolite from soy isoflavones: convenient preparation and resolution of R-and S- equols and their differing binding and biological activity through estrogen receptors alpha and beta [ J . Bioorganic & Medicinal Chemistry,2004,12 : 1559-1567. 被引量:1
  • 5李伟,丁明,张玉梅,王培玉.雌马酚对人乳腺癌MCF-7细胞生长的影响[J].中国食物与营养,2010,16(7):64-66. 被引量:7
  • 6任国峰,杨爱青,杨丽娜,朱明元,黄忆明.雌马酚对人卵巢癌SKOV-3细胞增殖的抑制作用及其机制研究[J].营养学报,2010,32(2):174-177. 被引量:3
  • 7Uesugi S, Watanabe S, Ishiwata N, et al. Effects of isoflavone supplements on bone metabolic markers and climacteric symptoms in Japanese women[ J .Biofactors ,2004,22 ( 1-4 ) :221-228. 被引量:1
  • 8Fujioka M, Uehara M, Wu J, et al. Equol, a metabolite of daidzein,inhibits bone loss in ovariectomized mice [ J ] .J Nutr, 2004,134(10) :2623-2627. 被引量:1
  • 9Hedlund TE, Johannes WU, Miller GJ. Soy isoflavonoid equol modulates the growth of benign and malignant prostatic epithelial cells in vitro [ J] .Prostate,2003,54:68-78. 被引量:1
  • 10Widyarini S, Spinks N, Husband AJ, et al. Isoflavonoid compounds from red clover ( Trifolium pratense ) protect from inflammation and immune suppression induced by UV radiation [ J ].Photochemistry and Photobiology, 2001,74 ( 3 ) :465-470. 被引量:1

二级参考文献22

  • 1ChenLM, YamadaSD, FuYS, etal. Molecular similarities between primary peritoneal and primary ovarian carcinomas [J]. Int J Gynecol Cancer 2003, 13: 749 755. 被引量:1
  • 2Sakauchi F, Khan MM, Mori M, et al. Dietary habits and risk of ovarian cancer death in a large scale cohort study (JACC study) in Japan [J]. NutrCancer 2007, 57: 138-145. 被引量:1
  • 3Zhang M, Xie X, Lee AH, et al. Soy and isoflavone intake are associated with reduced risk of ovarian cancer in southeast China [J]. Nutr Cancer, 2004, 49 :125-130. 被引量:1
  • 4This P, De la Rochefordiere A, Clough K, et al. Phytestrogens after breast cancer [J]. Endocr Relat Cancer, 2001, 8: 129-134. 被引量:1
  • 5Setchell KD, Brown NM, Lydeking, etal. The clinical importance of the metabolite equol-A clue to the effectiveness of soy and its isoflavones [J]. J Nutr2002, 132: 3577-3584. 被引量:1
  • 6Lacey JVJr, MinkPJ, Lubin JH, etal. Menopausalhormone replacement therapy andriskofovariancancer [J]. JAMA, 2002, 288: 334- 341. 被引量:1
  • 7Johnson GL, Lapadat R. Mitogen activated protein kinase pathways mediated by ERK, JNK andp38 protein kinases[J]. Science, 2002, 298: 1911-1912. 被引量:1
  • 8Krueger JS, Song RX, Mcpherson R, etal. Temporal and quantitative regulation of mitogen activated protein kinase (MAPK) modulates cell motility and invasion [J]. Oncogene, 2001, 20: 4209-4218. 被引量:1
  • 9Steelman LS, Pohnert SC, Shelton JG, et al. JAK/STAT, Raf /MEKERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis[]]. Leukemia, 2004, 18: 189- 218. 被引量:1
  • 10Platanias LC. MAP kinase signaling pathways and hematologic malignancies [J]. Blood 2003, 101: 4667 -4679. 被引量:1

共引文献7

同被引文献28

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部